Search "GMP-certified pharma company in India" and nearly every result — hundreds of them — claims the same badge: WHO-GMP certified, ISO certified, trusted franchise partner. The phrase has become so universal in pharma marketing that it's stopped functioning as a real filter. What's changed in 2026, though, is that verifying it properly now matters more than it ever has, because India's underlying GMP standard itself just went through its biggest overhaul in decades — and not every manufacturer claiming the badge has actually caught up to it.
This piece looks at what a GMP-certified pharma company claim actually needs to hold up in 2026, why Revised Schedule M enforcement changes what "verified" should mean, and how to check a manufacturer's real compliance status before signing a franchise or manufacturing agreement.
Why "GMP Certified" Became a Generic Claim
Nearly every PCD pharma franchise company in India markets itself as WHO-GMP or ISO certified — it's become a baseline claim rather than a genuine differentiator, repeated identically across thousands of franchise listings and company websites. That's not necessarily dishonest; many companies do hold real certifications. But the sheer repetition of the phrase means a prospective franchise partner or distributor can no longer treat "GMP certified" on a homepage as meaningful due diligence on its own.
What Changed in 2026: Revised Schedule M Enforcement
India's GMP standard, Schedule M under the Drugs and Cosmetics Rules, was substantially revised in December 2023 to align more closely with WHO-GMP and international quality benchmarks. Large manufacturers had to comply by mid-2024; smaller manufacturers received phased extensions, with the final deadline falling on January 1, 2026. The Drugs Controller General of India held that deadline firm, directing state regulators to begin inspections and warning that non-compliant units would face license suspension — a stance that hardened further after the deaths of children in India linked to contaminated cough syrup pushed enforcement from routine to urgent.
Reporting in the months leading up to the deadline suggested a meaningful share of small and medium manufacturers had not yet completed the required infrastructure and documentation upgrades, with the cost of retrofitting a single production line running anywhere from roughly ₹50 lakh to ₹1.5 crore depending on the starting point. That means two manufacturers can both legitimately claim "GMP certified" right now, while sitting on very different levels of actual compliance — one holding a certificate that reflects the older standard, the other having genuinely completed the revised requirements.
What Revised Schedule M Actually Requires
The updated standard goes meaningfully beyond the older rule's general hygiene and documentation checks:
| Requirement | What It Changes |
| Quality Risk Management systems | Moves from reactive inspection to proactive process control |
| Electronic Batch Manufacturing Records (eBMR) | Replaces paper logs with validated computerized systems |
| Product Quality Review (PQR) | Requires ongoing review for every marketed product, not a one-time check |
| Formal CAPA and change control | Tracks and resolves quality deviations systematically |
| Equipment and utility qualification | Validates infrastructure, not just finished-product testing |
A manufacturer that hasn't implemented these isn't just behind on paperwork — it's operating under a materially weaker quality framework than current regulation requires.
How to Actually Verify GMP Certification in 2026
A certificate on a website proves nothing on its own. Before entering any agreement:
- Ask for the certificate directly — check the issuing authority, issuance date, validity period, and the specific product categories it covers.
- Cross-check with CDSCO and the state FDA — India's Central Drugs Standard Control Organization lists licensed manufacturers, which lets you verify a claim independently rather than taking it on faith.
- Ask specifically about Revised Schedule M status — not just general WHO-GMP certification, but whether the facility has completed the 2026-mandated upgrades: eBMR implementation, documented CAPA processes, and recent inspection history.
- Request the endorsed product schedule — a valid certificate has a specific list of approved categories attached; confirm the product you need is actually on it.
- Visit the facility if at all possible — inspecting the manufacturing floor and quality control lab directly remains the single most reliable check available to any franchise partner or distributor.
Where Amplec Healthcare Fits This Picture
Amplec Healthcare is a WHO-GMP certified pharmaceutical company with over 15 years of manufacturing experience, producing tablets, capsules, syrups, injectables, softgels, and Ayurvedic formulations for PCD franchise and contract manufacturing partners. Its published quality policy documents how these standards apply across raw material sourcing, staff training, equipment validation, and finished-product testing — precisely the kind of documentation worth requesting from any manufacturer under consideration this year, not just taking on faith.
For franchise partners specifically evaluating the cardiac and diabetic segment, Amplec's guide to choosing the best cardiac diabetic PCD franchise company applies this same verification logic to a specific therapeutic category, alongside its broader product portfolio spanning eight manufacturing formats.
Questions Worth Asking Before You Sign
- Can they produce a current certificate with issuing authority, date, and covered product categories?
- Has the facility completed Revised Schedule M upgrades specifically, or is it still operating under the older standard?
- Can their CDSCO or state FDA listing be independently verified, not just claimed?
- Do they use electronic batch records, and can they show a documented CAPA process?
- Will they allow a facility visit before you commit to a franchise agreement or bulk order?
Final Word
"GMP certified" stopped being a meaningful differentiator the moment every company in the SERP started saying it. What actually separates a reliable manufacturer in 2026 is whether that certification reflects the current, revised standard — and whether the company is willing to show you the documentation rather than asking you to take the badge at face value.
For the complete verification checklist and franchise details, visit Amplec Healthcare's GMP-Certified Pharma Company page directly, check their FAQs, or get in touch to request current certification documentation.
Sign in to leave a comment.